Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytes

Journal of Gastroenterology

Volumn 47, Issue 1, 2012, Pages 49-55

  Yoshimura, Naoki ^a   Tadami, Tokuma ^a   Kawaguchi, Takaaki ^a   Sako, Minako ^a   Yoshimoto, Hiroshi ^a   Yamaka, Toshihiko ^a   Takazoe, Masakazu ^a  

^a Social Insurance Central General Hospital   (Japan)

Author keywords

Body weight; Granulocytes and monocytes adsorptive apheresis; Myeloid lineage leucocytes; Processed blood volume; Ulcerative colitis

Indexed keywords

ADULT; ADVERSE OUTCOME; APHERESIS; ARTICLE; BLOOD VOLUME; BODY WEIGHT; CELL LINEAGE; CLINICAL ACTIVITY INDEX; CLINICAL EFFECTIVENESS; COLONOSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOSCOPIC INDEX; FLUSHING; GRANULOCYTE AND MONOCYTE BY ADSORPTION APHERESIS; HEADACHE; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MYELOID LEUCOCYTE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCESSED BLOOD VOLUME; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SAFETY; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BLOOD VOLUME; BODY WEIGHT; COLITIS, ULCERATIVE; COLONOSCOPY; HUMANS; LEUKAPHERESIS; MONOCYTES; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857626476     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0464-0     Document Type: Article

References (37)

1. SB Hanauer 2006 Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities Inflamm Bowel Dis 12 S3 S9 16378007 10.1097/01.MIB.0000195385.19268.68 (Pubitemid 43068428)
2. Allison MC, Dhillon AP, Lewis WG, Pounder RE, editors. Inflammatory bowel disease. London: Mosby; 1998. p. 9-95.
3. DH Present 2000 How to do without steroids in inflammatory bowel disease Inflamm Bowel Dis 6 48 57 10701150 10.1002/ibd.3780060110 1:STN:280: DC%2BD3c7msF2ktQ%3D%3D
4. HM van Dullemen SJ van Deventer DW Hommes 1995 Treatment of Crohn's disease with anti-tumour necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 129 135 7797011 10.1016/0016-5085(95)90277-5
5. P Rutgeerts WJ Sandborn BG Feagan W Reinisch A Olson J Johanns, et al. 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2462 2476 16339095 10.1056/NEJMoa050516 1:CAS:528: DC%2BD2MXhtlShurjE (Pubitemid 41770166)
6. DA McCarthy DS Rampton Y-C Liu 1991 Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease Clin Exp Immunol 86 489 493 1684141 10.1111/j.1365-2249.1991. tb02958.x 1:STN:280:DyaK38%2FotlKmug%3D%3D
7. JA Tibble G Sigthorsson I Bjarnason 2000 Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease Gastroenterology 119 15 22 10889150 10.1053/gast.2000.8523 1:STN:280:DC%2BD3czkvFCjuw%3D%3D (Pubitemid 30452574)
8. B Passlick D Flieger HW Ziegler-Heitbrock 1989 Identification and characterization of a novel monocyte subpopulation in human peripheral blood Blood 74 2527 2534 2478233 1:STN:280:DyaK3c%2FivVOqug%3D%3D (Pubitemid 19286475)
9. KU Belge F Dayyani A Horelt 2002 The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF J Immunol 168 3536 3542 11907116 1:CAS:528:DC%2BD38Xis1ajtLY%3D (Pubitemid 34250422)
10. H Hanai T Iida K Takeuchi F Watanabe M Yamada M Kikuyama, et al. 2008 Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease Am J Gastroenterol 103 1210 1216 18177452 10.1111/j.1572-0241.2007.01714.x (Pubitemid 351677962)
11. RD Cohen 2005 Treating ulcerative colitis without medications-"Look Mom, no drugs!" Gastroenterology 128 235 236 15633142 10.1053/j.gastro. 2004.11.024 (Pubitemid 40039976)
12. BE Sands WJ Sandborn B Feagan R Löfberg T Hibi MK Vandervoort, et al. 2008 A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis Gastroenterology 135 400 409 18602921 10.1053/j.gastro.2008.04.023 1:CAS:528:DC%2BD1cXhtVCqsL%2FM
13. AR Saniabadi H Hanai K Takeuchi K Umemura M Nakashima T Adachi, et al. 2003 Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes Ther Apher Dial 7 48 59 12921115 10.1046/j.1526-0968.2003.00012.x (Pubitemid 36648043)
14. T Shimoyama K Sawada N Hiwatashi T Sawada K Matsueda A Munakata, et al. 2001 Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study J Clin Apher 16 1 9 11309823 10.1002/jca.1000 1:STN:280:DC%2BD3M3hvFaitg%3D%3D (Pubitemid 32374496)
15. H Hanai F Watanabe K Takeuchi T Iida M Yamada Y Iwaoka, et al. 2003 Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled study Clin Gastroenterol Hepatol 1 28 35 15017514 10.1053/jcgh.2003.50005 (Pubitemid 37254469)
16. Y Suzuki N Yoshimura AR Saniabadi Y Saito 2004 Selective granulocytes and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study Dig Dis Sci 49 565 571 15185858 10.1023/B:DDAS.0000026299.43792.ae 1:CAS:528:DC%2BD2cXjs1WqurY%3D (Pubitemid 38992542)
17. Saniabadi AR, Hanai H, Suzuki Y, Ohmori T, Sawada K, Yoshimura N, et al. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher. 2005;20:171-84. (Pubitemid 43081867)
18. V Muratov J Lundahl AK Ulfgren K Elvin I Fehrman N Ahlborg, et al. 2006 Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study Int J Colorectal Dis 21 493 504 16538495 10.1007/s00384-005- 0069-2 1:STN:280:DC%2BD28vjsVCiug%3D%3D (Pubitemid 44111274)
19. L Maiden K Takeuchi R Baur I Bjarnason J O'Donohue I Forgacs, et al. 2008 Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse Inflamm Bowel Dis 14 1413 1418 18521900 10.1002/ibd.20505
20. M Naganuma S Funakoshi A Sakuraba H Takagi N Inoue H Ogata, et al. 2004 Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis Inflamm Bowel Dis 10 251 257 15290920 10.1097/00054725-200405000-00012 (Pubitemid 38618255)
21. T Yamamoto S Umegae T Kitagawa 2004 Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study Aliment Pharmacol Ther 20 783 792 15379839 10.1111/j.1365-2036.2004. 02189.x 1:STN:280:DC%2BD2cvmvFSjtQ%3D%3D (Pubitemid 39319234)
22. E Domènech J Hinojosa M Esteve-Comas F Gomollón JM Herrera G Bastida, et al. 2004 Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study Aliment Pharmacol Ther 20 1347 1352 15606397 10.1111/j.1365-2036.2004.02288.x (Pubitemid 40040082)
23. Y Suzuki N Yoshimura K Fukuda K Shirai Y Saito AR Saniabadi 2006 A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis Dig Dis Sci 51 2031 2038 17004123 10.1007/s10620-006-9199-9 (Pubitemid 44832586)
24. T Tanaka H Okanobu S Yoshimi E Murakami A Kogame H Imagawa, et al. 2008 In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients Dig Liver Dis 40 731 736 18387860 10.1016/j.dld.2008.02.012 1:STN:280:DC%2BD1cvptFCqsA%3D%3D
25. H Hanai F Watanabe M Yamada Y Sato K Takeuchi T Iida, et al. 2004 Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis Digestion 70 36 44 15297776 10.1159/000080079 1:CAS:528:DC%2BD2cXntFSgtr8%3D (Pubitemid 39179238)
26. T Hibi Y Sameshima Y Sekiguchi Y Hisatome F Maruyama K Moriwaki, et al. 2009 Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan Dig Liver Dis 41 570 577 19211314 10.1016/j.dld.2008.11.020 1:CAS:528:DC%2BD1MXhsFaqtLnJ
27. D Rachmilewitz on behalf of an international study group 1989 Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial Br Med J 298 82 86 10.1136/bmj.298.6666.82 1:STN:280:DyaL1M7ltVOitg%3D%3D (Pubitemid 19032930)
28. AR Saniabadi H Hanai K Fukunaga K Sawada C Shima I Bjarnason, et al. 2007 Therapeutic leucocytapheresis for inflammatory bowel disease Transf Apher Sci 37 191 200 10.1016/j.transci.2007.08.003 (Pubitemid 350186259)
29. SB Hanauer 2004 Medical therapy of ulcerative colitis Gastroenterology 126 1582 1592 15168369 10.1053/j.gastro.2004.02.071 (Pubitemid 38649875)
30. G D'Haens L Lemmens K Geboes 2001 Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis Gastroenterology 120 1323 1329 11313301 10.1053/gast.2001.23983 (Pubitemid 32322305)
31. SB Hanauer 2001 Can cyclosporine go it alone in severe ulcerative colitis Curr Gastroenterol Rep 3 455 456 11696281 10.1007/s11894-001-0064-x 1:STN:280:DC%2BD3MnksVSqsQ%3D%3D
32. SL Taffet KM Das 1983 Sulfasalazine-adverse effects and desensitization Dig Dis Sci 28 833 842 6136396 10.1007/BF01296907 1:STN:280:DyaL3s3os12hsA%3D%3D
33. T Tanaka H Okanobu Y Kuga Y Yoshifuku H Fujino T Miwata, et al. 2010 Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis Gastroenterol Clin Biol 34 687 695 20934287 10.1016/j.gcb.2010.08.007
34. AR Saniabadi H Hanai 2010 Therapeutic apheresis from the early civilizations to the twenty-first century Gastroenterol Clin Biol 34 645 648 20971590 10.1016/j.gcb.2010.09.003 1:STN:280:DC%2BC3M%2Fjt1agtQ%3D%3D
35. A Sakuraba S Motoya K Watanabe M Nishishita K Kanke Y Suzuki, et al. 2009 An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment Am J Gastroenterol 104 2990 2995 19724269 10.1038/ajg.2009.453
36. H Hanai Y Takeda M Eberhardson R Gruber AR Saniabadi O Winqvist, et al. 2011 The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review Clin Exp Immunol 163 50 58 21078086 10.1111/j.1365-2249.2010.04279.x 1:CAS:528:DC%2BC3MXnvFSmtg%3D%3D
37. K Kanke M Nakano H Hiraishi A Terano 2004 Evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis Dig Liv Dis 36 512 518 10.1016/j.dld.2004.08.004 (Pubitemid 41070579)